AIT for pain relief in pancreatic cancer
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This trial tests a treatment called AIT for severe pain from pancreatic cancer that isn't helped by standard painkillers or causes bad side effects. It may offer a new option to better manage your pain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 20 years or older
- You have pancreatic cancer confirmed by a biopsy
- Your pain is chronic and not well controlled with usual pain medicines, or you can't take those medicines because of side effects or allergies
- You are not taking more than 120 mg of morphine (or equivalent) per day
- You agree to fill out study questionnaires and follow the study plan
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a targeted radiation treatment to a nerve bundle in the abdomen (called the coeliac plexus) can reduce pain in people with advanced pancreatic cancer. If you have significant pain that isn't controlled by your current medications, this approach may help improve your comfort and quality of life.
This trial compares a treatment that delivers pain medicine directly to the spinal cord (intrathecal therapy) with usual pain control. It is for people with severe cancer pain that is not helped by oral or intravenous opioids.
This study compares two ways to manage pain after a Whipple procedure: one is a shot of morphine into the fluid around the spine, and the other is a small tube placed under the skin at the surgical cut that delivers pain medicine continuously. The goal is to see which method provides better pain relief and recovery.
This trial tests whether an epidural (a numbing shot near the spine) can reduce pain and improve recovery in people with severe pancreatitis who have early problems with their lungs, heart, or kidneys. It is designed for people in the intensive care unit.
This Phase 1 trial tests a new drug related to capsaicin (resiniferatoxin) to reduce severe nerve pain from advanced cancer. It is given through a small catheter near the spinal fluid space and is meant for people whose pain medicines and other options have not worked well enough.
This trial tests a treatment called transcatheter arterial infusion, where chemotherapy drugs are delivered directly to the tumor through a thin tube in an artery. It's for people with advanced pancreatic cancer who haven't had other treatments yet.
Hear when a new Pancreatic Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.